Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Age-related differences in antithrombotic therapy, success rate and in-hospital mortality in patients undergoing percutaneous coronary intervention: results of the quality control registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).

Schwarz AK, Zahn R, Hochadel M, Kerber S, Hauptmann KE, Glunz HG, Mudra H, Darius H, Zeymer U.

Clin Res Cardiol. 2011 Sep;100(9):773-80. doi: 10.1007/s00392-011-0311-6. Epub 2011 Apr 21.

PMID:
21509588
2.

Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.

Feldman DN, Minutello RM, Bergman G, Moussa I, Wong SC.

Catheter Cardiovasc Interv. 2010 Oct 1;76(4):513-24. doi: 10.1002/ccd.22546.

PMID:
20882655
3.

Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.

Wojtkowska I, Stępińska J, Stępień-Wojno M, Sobota M, Kopaczewski J, Reszka Z, Kurzelewski M, Medina J.

Kardiol Pol. 2017;75(5):445-452. doi: 10.5603/KP.a2017.0034. Epub 2017 Mar 10.

5.

Treatment patterns in acute coronary syndrome patients in the United Kingdom undergoing PCI.

Bakhai A, Iñiguez A, Ferrieres J, Schmitt C, Sartral M, Belger M, Zeymer U; APTOR trial investigators.

EuroIntervention. 2011 Mar;6(8):992-6. doi: 10.4244/EIJV6I8A171.

6.

Age-related differences in diagnosis, treatment and outcome of acute coronary syndromes: results from the German ALKK registry.

Rittger H, Hochadel M, Behrens S, Hauptmann KE, Zahn R, Mudra H, Brachmann J, Senges J, Zeymer U.

EuroIntervention. 2012 Feb;7(10):1197-205. doi: 10.4244/EIJV7I10A191.

7.

Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.

Dörler J, Edlinger M, Alber HF, Altenberger J, Benzer W, Grimm G, Huber K, Pachinger O, Schuchlenz H, Siostrzonek P, Zenker G, Weidinger F; Austrian Acute PCI Investigators.

Eur Heart J. 2011 Dec;32(23):2954-61. doi: 10.1093/eurheartj/ehr360. Epub 2011 Sep 14.

PMID:
21920970
8.

Prior antiplatelet use and cardiovascular outcomes in patients presenting with acute coronary syndromes.

El-Menyar A, AlHabib KF, Al-Motarreb A, Hersi A, Al Faleh H, Asaad N, Al Saif S, Almahmeed W, Sulaiman K, Amin H, Al-Lawati J, Alsheikh-Ali AA, AlQahtani A, Al-Sagheer NQ, Singh R, Al Suwaidi J.

Am J Cardiovasc Drugs. 2012 Apr 1;12(2):127-35. doi: 10.2165/11597580-000000000-00000.

PMID:
22257172
9.

[Temporal evolution of antithrombotic therapy use in patients with acute coronary syndromes undergoing percutaneous coronary intervention in Italy: comparison between the EYESHOT and SCOPE registries].

De Luca L, Pennacchi M, Musumeci G, D'Ascenzo F, Gallo P, Rigattieri S, Granatelli A, Berti S, Gulizia MM, De Servi S, Bolognese L; a nome dei Ricercatori EYESHOT e SCOPE.

G Ital Cardiol (Rome). 2018 Feb;19(2):101-110. doi: 10.1714/2868.28941. Italian.

PMID:
29531382
10.

Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).

Kunadian V, James SK, Wojdyla DM, Zorkun C, Wu J, Storey RF, Steg PG, Katus H, Emanuelsson H, Horrow J, Maya J, Wallentin L, Harrington RA, Gibson CM.

JACC Cardiovasc Interv. 2013 Jul;6(7):671-83. doi: 10.1016/j.jcin.2013.03.014.

11.

Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Harrington RA, Becker RC, Cannon CP, Gutterman D, Lincoff AM, Popma JJ, Steg G, Guyatt GH, Goodman SG.

Chest. 2008 Jun;133(6 Suppl):670S-707S. doi: 10.1378/chest.08-0691.

PMID:
18574276
12.

Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.

Christ G, Siller-Matula JM, Francesconi M, Dechant C, Grohs K, Podczeck-Schweighofer A.

BMJ Open. 2014 Oct 31;4(10):e005781. doi: 10.1136/bmjopen-2014-005781.

13.

Use and outcome of radial versus femoral approach for primary PCI in patients with acute ST elevation myocardial infarction without cardiogenic shock: results from the ALKK PCI registry.

Bauer T, Hochadel M, Brachmann J, Schächinger V, Boekstegers P, Zrenner B, Zahn R, Zeymer U; Arbeitsgemeinschaft leitende kardiologische Krankenhausärzte (ALKK).

Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S8-14. doi: 10.1002/ccd.25987. Epub 2015 May 6.

PMID:
25945803
14.

Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).

Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, Bonzel T, Senges J, Neuhaus KL; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).

Eur Heart J. 2004 Feb;25(4):322-8.

PMID:
14984921
15.

Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR]).

Damman P, Varenhorst C, Koul S, Eriksson P, Erlinge D, Lagerqvist B, James SK.

Am J Cardiol. 2014 Jan 1;113(1):64-9. doi: 10.1016/j.amjcard.2013.09.019. Epub 2013 Oct 3.

PMID:
24169009
16.
17.

Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.

Kurz DJ, Radovanovic D, Seifert B, Bernheim AM, Roffi M, Pedrazzini G, Windecker S, Erne P, Eberli FR.

Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):13-22. doi: 10.1177/2048872614566946. Epub 2015 Jan 22.

PMID:
25614494
18.

Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

Lincoff AM, Steinhubl SR, Manoukian SV, Chew D, Pollack CV Jr, Feit F, Ware JH, Bertrand ME, Ohman EM, Desmet W, Cox DA, Mehran R, Stone GW; Acute Catheterization and Urgent Intervention Triage strategY of Trial Investigators.

JACC Cardiovasc Interv. 2008 Dec;1(6):639-48. doi: 10.1016/j.jcin.2008.10.004.

19.

Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).

Bromberg-Marin G, Marin-Neto JA, Parsons LS, Canto JG, Rogers WJ; National Registry of Myocardial Infarction-4.

Am J Cardiol. 2006 Nov 1;98(9):1125-31. Epub 2006 Aug 31.

PMID:
17056312
20.

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome.

Pham SV, Pham PC, Pham PM, Miller JM, Pham PT, Pham PA.

Drug Des Devel Ther. 2010 Sep 7;4:203-20. doi: 10.2147/DDDT.S12056. Review.

Supplemental Content

Support Center